Journal article
Immune biomarkers in the prediction of future myocardial infarctions in people with human immunodeficiency virus
JM Trevillyan, C Moser, JS Currier, T Sallam
Clinical Infectious Diseases | Published : 2020
DOI: 10.1093/cid/ciz765
Abstract
In a retrospective case control analysis, following adjustments for high-sensitivity C-reactive protein (hsCRP), traditional cardiovascular risk factors, and the CD4/CD8 T-cell ratio, higher lipopolysaccharide-binding protein (LBP) was associated with future myocardial infarctions in hsCRP human immunodeficiency virus (HIV). LBP may be a marker of cardiovascular risk with utility in HIV.
Related Projects (1)
Grants
Awarded by National Heart, Lung, and Blood Institute
Funding Acknowledgements
This work was supported by the University of California, Los Angeles Center for AIDS Research (grant number 5P30 AI028697 for administrative support; grant numbers DK118086 and HL139549 for technical staff), the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award numbers UM1 AI068634, UM1 AI068636, and UM1 AI106701), and the AIDS Clinical Trials Group Specimen Repository Pilot (grant number 116529:1).